MB

MPM BioImpact Portfolio holdings

AUM $611M
1-Year Est. Return 29.61%
This Quarter Est. Return
1 Year Est. Return
+29.61%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$427M
AUM Growth
+$52.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
34
New
Increased
Reduced
Closed

Top Buys

1
+$18.8M
2
+$3.57M
3
+$2.89M
4
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$23.3K
5
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$21.8K

Top Sells

1
+$5.73M
2
+$5.57M
3
+$4.94M
4
NTLA icon
Intellia Therapeutics
NTLA
+$4.94M
5
VRDN icon
Viridian Therapeutics
VRDN
+$3.38M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$6.05M 1.42%
325,284
+284
27
$4.04M 0.95%
5,095,912
28
$3.63M 0.85%
319,670
29
$2.89M 0.68%
+50,000
30
$2.18M 0.51%
100,000
-155,323
31
$1.38M 0.32%
323,813
-3,108
32
$639K 0.15%
70,000
-277,332
33
– –
-552,846
34
– –
-577,958
1
2